MDXG
NASD MiMedx Group, Inc.$3.90 ↓ -0.33 (-7.80%) Trading Down from the previous close of $4.23, $0.30 below the day’s high of $4.20
- YTD change
- -42.39%
- vs 20-day SMA
- -15.58%
- vs 200-day SMA
- -10.59%
Price ranges
Price & Performance
+1.03 (+32.19%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 78.6% away from all-time highs of $18.25
- MDXG is down 42% since the beginning of the year
- MDXG is down 42% over the past 12 months
- MDXG is down 21% over the past 1 month
- 8% of all MDXG investors are betting against MDXG
MDXG reads poor: price sits below both the 20- and 200-day averages, the 12-month move is -37.2%.
- Previous minute
- +$0.01
- Last hour
- +$0.03
- Last 5 days
- -16.84%
- vs 8-day SMA
- -14.78%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
MiMedx Group, Inc. is a therapeutic biologics company, which engages in the design, manufacture, and marketing of products, and tissue processing services. It serves the wound care, burn, surgical, orthopedic, spine, sports medicine, ophthalmic, and dental sectors of healthcare. Its biomaterial platform technologies include AmnioFix and EpiFix, a tissue allografts derived from amnion and chorion layers of human placental membrane, EpiCord and AmnioCord, a tissue allografts derived from umbilical cord tissue, and AmnioFill, a placental connective tissue matrix derived from the placental disc and other placental tissue. The company was founded on July 30, 1985 and is headquartered in Marietta, GA.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.
